T.I.3 Antisense Oligonucleotide (AON) mediated exon skipping trials in Duchenne Muscular Dystrophy (DMD): Current status, future prospects and challenges
N. GoemansVolume:
21
Year:
2011
Language:
english
DOI:
10.1016/j.nmd.2011.06.959
File:
PDF, 45 KB
english, 2011